ANN ARBOR STAGE IV HODGKIN LYMPHOMA

Clinical trials for ANN ARBOR STAGE IV HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ANN ARBOR STAGE IV HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for ANN ARBOR STAGE IV HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 2 Completed 1

New hope for kids with Hard-to-Treat cancers: targeted drug shows promise

Disease control Completed

This study tested a drug called tazemetostat in 20 children whose cancers had come back or weren't responding to treatment. The children had specific gene changes (EZH2, SMARCB1, or SMARCA4) in their tumors. The goal was to see if the drug could shrink or slow the growth of these…

Matched conditions: ANN ARBOR STAGE IV HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 26, 2026 09:35 UTC

ANN ARBOR STAGE IV HODGKIN LYMPHOMA

Get alerted when new ANN ARBOR STAGE IV HODGKIN LYMPHOMA trials appear

New hope for kids with Hard-to-Treat cancers: targeted drug shows promise